What is Treatobacco.net?
Treatobacco.net is a Society for Research on Nicotine and Tobacco (SRNT) website that offers information on the treatment of tobacco dependence to health and other professionals, including researchers, those who create and advocate policy, doctors, nurses, pharmacists, dentists and others.
The treatment of tobacco dependence is a popular subject for research and finding evidence-based, authoritative data can be time-consuming. Treatobacco.net was developed in 2000 to bring the best information together in a single, independent website.
History of Treatobacco.net
Since 2008 treatobacco.net has been supported only by organisations like the American Cancer Society, the Society for the Study of Addiction (UK), Global Bridges, the World Lung Foundation, the Society for Research on Nicotine and Tobacco, the National Centre for Smoking Cessation and Training (UK), and does not receive funding from the pharmaceutical industry.
The core scientific content of the site is contained in six sections, which summarise the evidence on treatment under the headings: Efficacy, Safety, Demographics and health effects, Health economics, Policy, and Electronic cigarettes.
The content is written by world experts and reviewed by an independent Editorial board also comprised of world experts, and appears in 11 languages: English, Arabic, Chinese, Czech, French, German, Italian, Japanese, Portuguese, Russian, and Spanish.
About 18,000 people visit the site each month, most going to these main sections. Other content includes the Resource Library, which contains downloadable slide kits of the main sections, links to national treatment guidelines (the most popular downloads), reports, and links to other reports (eg. FCTC) and organisations. On the home page, you can find papers of interest highlighted as headlines, and a Latest Additions column, which announces conferences, training, reports, new scientific papers, etc. There is also an Ask the Experts feature, which includes short, specially written articles. Examples include “What is varenicline?”, “What is cytisine?”.
Most visits are from the USA (about 48%), followed by China, UK, Germany, France, Brazil, Russian Federation, Ukraine, Japan, Spain, Canada, Australia, India, some Arabic speaking countries, and a few others – more than 150 countries every month.
Future of Treatobacco.net
We are designing a new section, which we hope to launch in the new year, to bring together in one place documents and resources connected with the implementation of FCTC Article 14 and its guidelines, which were adopted by the Conference to the Parties in 2010. Article 14 concerns tobacco cessation and treatment and obliges Parties to offer comprehensive tobacco cessation help.
The guidelines in effect represent official policy on treatment for 178 countries, most of the world, and this new section will offer easy access to our library of national cessation strategies, national cessation guidelines (more than 30 available), tools to help countries implement Article 14 – developed by Martin Raw through his Bloomberg Philanthropies funded project – country experiences (case studies), articles, links, and more.
In summary, www.treatobacco.net is a dynamic and expanding resource for healthcare professionals, scientists and policy makers, and anyone interested in tobacco dependence treatment, presenting information in 11 languages, free. We hope you find it useful and welcome feedback on it.
About the Author: Jacques Le Houezec is the manager of Treatobacco.net. He is a freelance consultant, Rennes, France; Special Lecturer, UK Centre for Tobacco Control Studies, Division of Epidemiology and Public Health, University of Nottingham, Nottingham, UK.